Because of the limitation of the published data, we were unable to assess the relationship of other CD24 polymorphisms, such as the −809 C/A, −534A/C and −492G/C polymorphisms in the promoter region with MS and SLE. The gene discussed is CD24; the disease is myeloid sarcoma.